BridgeMD
New treatment option for Arterial Hypertension
Official title Effects of Resistance Training Intensity on Cardiovascular Parameters of Hypertensive Women
ClinicalTrials.gov ID: NCT06538454
What this study is testing
- What it's testing
- The goal of this clinical trial is to understand about the effects of resistance training (RT) intensity on cardiovascular parameters in postmenopausal women with systemic arterial hypertension (SAH). The main research questions are: Does the intensity of RT impact blood pressure (BP) in postmenopausal women with SAH?
- Time commitment: about 10 weeks
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 to 65, women only
You may be able to join if
- Women with 50 to 65 old years;
- Postmenopausal diagnosis (amenorrhea for 12 months or more);
- Previous diagnosis of hypertension and treat with medications;
- Physically inactive.
You likely can't join if
- History of other cardiovascular problems (heart failure, heart attack, stroke, etc);
- Grade II obesity (BMI ≥ 35 kg/m²);
- Medications (beta-blockers and/or non-dihydropyridine calcium channel blockers);
- Systolic blood pressure at rest above 160 mmHg and/or dyastolic blood presure above 105 mmHg;
- Unable to perform resistance exercise due to musculoskeletal or cognitive reasons.
The study team makes the final eligibility decision.
Where it's taking place
- Ribeirão Preto, São Paulo, Brazil
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 10 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling female, 50 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ribeirão Preto, São Paulo, Brazil. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.